File(s) not publicly available
The science of nations: European multinationals and American biotechnology
journal contribution
posted on 2023-06-07, 23:16 authored by Margaret SharpThis paper examines how Europe's large chemical/pharmaceutical multinationals have developed their interests and capabilities in biotechnology and in particular the degree to which, in the process, they have become increasingly linked into the US science base. It looks at both direct linkages via subsidiary laboratories located on US soil and at indirect linkages via the small, dedicated biotechnology companies. It concludes that, although the picture is mixed, many of these major European firms are now deeply embedded by these two routes into the American science base. However, far from this being ''exploitation'', the US in most respects is the gainer, for these linkages are creating high value added jobs for Americans on American soil. For Europe, the key issue is how far these firms are internally transferring the technology back to home-based laboratories. Unless this is happening, Europe risks the cumulative loss of leading edge capabilities.
History
Publication status
- Published
Journal
International Journal of BiotechnologyISSN
0963-6048Publisher
InderscienceExternal DOI
Issue
1Volume
1Page range
132-162ISBN
0963-6048Department affiliated with
- SPRU - Science Policy Research Unit Publications
Full text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2012-02-06Usage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC